Cours suspendu

Autres langues RAPT Therapeutics, Inc.

Actions

RAPT

US75382E2081

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 02/03/2026			Varia. 5j.	Varia. 1 janv.
58,02 ^USD	+0,07%		-.--%	+71,30%

04/03	GSK a finalisé l'acquisition de RAPT Therapeutics
03/03	Levée de fonds pour Rosebank ; Surface Transforms perd son contrat avec GM	AN

Autres langues

04/03	Wenn schon das Gerede über Gespräche die Märkte bewegt
04/03	When Talk of Talks Moves Markets
04/03	Morning Meeting: Erinnerung an 2022
04/03	Remember 2022
03/03	Rosebank fundraise; Surface Transforms loses GM deal
03/03	GSK plc completed the acquisition of 93.4% stake in RAPT Therapeutics, Inc. for $1.7 billion.
03/03	GSK Completes Purchase of RAPT Therapeutics
03/03	GSK Wraps Up $2.2 Billion Deal to Buy US-based Rapt Therapeutics
03/03	RAPT Therapeutics, Inc. Announces Management Changes
03/03	RAPT Therapeutics, Inc.(NasdaqGM:RAPT) dropped from S&P Biotechnology Select Industry Index
03/03	RAPT Therapeutics, Inc.(NasdaqGM:RAPT) dropped from S&P Global BMI Index
03/03	RAPT Therapeutics, Inc.(NasdaqGM:RAPT) dropped from S&P TMI Index
03/03	RAPT Therapeutics, Inc.(NasdaqGM:RAPT) dropped from NASDAQ Composite Index
02/03	RAPT Therapeutics, Inc.(NasdaqGM:RAPT) dropped from NASDAQ Biotechnology Index
25/02	GSK kauft kanadische 35Pharma für 950 Millionen US-Dollar
25/02	GSK stärkt sich mit Milliarden-Zukauf
25/02	GSK to Buy 35Pharma for $950 Million -- Update
25/02	GSK to buy 35Pharma for $950 million in CEO Miel's second major deal
12/02	Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
12/02	Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?
06/02	Halper Sadeh LLC is Investigating Whether NWE, DHIL, RAPT are Obtaining Fair Prices for its Shareholders
05/02	RAPT Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RAPT Therapeutics, Inc. - RAPT
04/02	GSK eyes sharper, faster drug development as new CEO signals growth plan
21/01	RAPT Therapeutics Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RAPT Therapeutics, Inc. - RAPT
21/01	GSK von seinen Aktionären aufgefordert, seine Neuerfindung zu beschleunigen